| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.09T | 1.11T | 1.08T | 1.03T | 1.02T | 866.70B |
| Gross Profit | 148.44B | 153.98B | 145.60B | 133.82B | 135.25B | 120.50B |
| EBITDA | 66.68B | 31.19B | 65.11B | 57.24B | 50.52B | 46.67B |
| Net Income | 23.22B | 22.18B | 23.26B | 20.85B | 18.60B | 16.90B |
Balance Sheet | ||||||
| Total Assets | 714.33B | 751.70B | 681.21B | 671.80B | 637.23B | 548.60B |
| Cash, Cash Equivalents and Short-Term Investments | 49.71B | 54.14B | 49.24B | 37.94B | 33.68B | 24.95B |
| Total Debt | 299.80B | 306.88B | 270.91B | 284.35B | 301.14B | 250.60B |
| Total Liabilities | 444.20B | 460.21B | 405.82B | 426.32B | 424.71B | 360.71B |
| Stockholders Equity | 226.53B | 247.24B | 229.57B | 207.13B | 178.31B | 160.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.88B | 18.67B | 35.42B | -20.93B | 4.76B |
| Operating Cash Flow | 0.00 | 22.46B | 37.68B | 52.08B | -574.00M | 19.58B |
| Investing Cash Flow | 0.00 | -23.25B | -4.54B | -20.86B | -25.51B | -12.02B |
| Financing Cash Flow | 0.00 | 3.62B | -25.20B | -29.49B | 32.49B | -15.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥60.10B | 8.50 | ― | 2.44% | 3.38% | 57.67% | |
64 Neutral | ¥32.10B | 9.20 | ― | 0.72% | 6.21% | 167.11% | |
63 Neutral | ¥69.85B | 22.50 | ― | 0.34% | 10.22% | 13.91% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | ¥3.82B | 20.59 | ― | 0.95% | 3.83% | 2.51% | |
56 Neutral | ¥196.68B | 9.92 | 7.56% | 2.84% | 2.53% | -4.69% | |
56 Neutral | ¥89.31B | 10.54 | ― | 3.59% | 6.25% | 246.08% |